2025
SJR Q1
JCR Q1 · 8,5
41 matched articles
SCIE
Journal detail
European Journal of Vascular and Endovascular Surgery
- Publisher
- W.B. Saunders Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
1078588415322165
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,75
- Quartile Q1
- H-Index 150
- Cites/doc 3,14
- Docs (3y) 1.166
- Cites (3y) 3.413
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 8,5
- 5Y JIF 6,6
- JCI 2,71
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cardiology and Cardiovascular Medicine Q1
- Surgery Q1
Areas
- Medicine
WoS categories
- Surgery | Peripheral Vascular Diseases
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,75 | 8,5 | 6,6 | 2,71 | Q1 | 150 |
| 2024 | Q1 | Q1 | 1,512 | 6,8 | 6,5 | 2,21 | Q1 | 144 |
| 2023 | Q1 | Q1 | 1,33 | 5,7 | 6,2 | 1,82 | Q1 | 144 |
| 2022 | Q1 | Q1 | 1,341 | 5,7 | 6,3 | 1,82 | Q1 | 144 |
| 2021 | Q1 | Q1 | 1,289 | 6,4 | 6,1 | 1,74 | Q1 | 144 |
| 2020 | Q1 | Q1 | 1,698 | 7,1 | 6 | 1,75 | Q1 | 144 |
| 2019 | Q1 | Q1 | 1,634 | 5,3 | 4,7 | 1,51 | Q1 | 144 |
| 2018 | — | Q1 | — | 3,6 | 3,9 | 1,27 | Q1 | — |
| 2017 | Q1 | Q1 | 1,917 | 3,9 | 3,5 | 1,23 | Q1 | 144 |
| 2016 | Q1 | Q1 | 1,816 | 4,1 | 3,5 | — | — | 144 |
| 2015 | Q1 | Q1 | 1,704 | 2,9 | 3 | — | — | 144 |
| 2014 | Q1 | Q2 | 1,7 | 2,5 | 3 | — | — | 144 |
| 2013 | Q1 | Q1 | 1,814 | 3,1 | 2,9 | — | — | 144 |
| 2012 | Q1 | Q1 | 1,723 | 2,8 | 2,9 | — | — | 144 |
| 2011 | Q1 | Q1 | 1,61 | 3 | 2,9 | — | — | 144 |
| 2010 | Q1 | Q1 | 1,68 | 2,9 | 2,9 | — | — | 144 |
| 2009 | — | Q1 | — | 2,9 | 2,7 | — | — | — |
| 2008 | — | Q1 | — | 3 | 2,7 | — | — | — |
| 2007 | — | Q1 | — | 2,2 | 2,1 | — | — | — |
| 2006 | — | Q1 | — | 2,2 | — | — | — | — |
| 2005 | — | Q1 | — | 2 | — | — | — | — |
| 2004 | — | Q2 | — | 1,7 | — | — | — | — |
| 2003 | — | Q2 | — | 1,8 | — | — | — | — |
| 2002 | — | Q2 | — | 1,5 | — | — | — | — |
| 2001 | — | Q2 | — | 1,5 | — | — | — | — |
| 2000 | — | Q2 | — | 1,6 | — | — | — | — |
| 1999 | — | Q2 | — | 1,3 | — | — | — | — |
| 1998 | — | Q1 | — | 1,6 | — | — | — | — |
| 1997 | — | Q1 | — | 1,5 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 9/100 |
| 2025 | SURGERY | SCIE | Q1 | Q1 | 6/321 |
| 2024 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 10/98 |
| 2024 | SURGERY | SCIE | Q1 | Q1 | 9/314 |
| 2023 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 10/96 |
| 2023 | SURGERY | SCIE | Q1 | Q1 | 13/292 |
| 2022 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 14/68 |
| 2022 | SURGERY | SCIE | Q1 | Q1 | 14/213 |
| 2021 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 13/67 |
| 2021 | SURGERY | SCIE | Q1 | Q1 | 16/213 |
| 2020 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 7/65 |
| 2020 | SURGERY | SCIE | Q1 | Q1 | 9/211 |
| 2019 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 8/65 |
| 2019 | SURGERY | SCIE | Q1 | Q1 | 8/210 |
| 2018 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 16/65 |
| 2018 | SURGERY | SCIE | Q1 | Q1 | 28/203 |
| 2017 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | Q1 | 12/65 |
| 2017 | SURGERY | SCIE | Q1 | Q1 | 19/200 |
| 2016 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 13/63 |
| 2016 | SURGERY | SCIE | Q1 | — | 15/197 |
| 2015 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 28/63 |
| 2015 | SURGERY | SCIE | Q1 | — | 39/200 |
| 2014 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 33/60 |
| 2014 | SURGERY | SCIE | Q2 | — | 52/198 |
| 2013 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 21/65 |
| 2013 | SURGERY | SCIE | Q1 | — | 26/204 |
| 2012 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 25/68 |
| 2012 | SURGERY | SCIE | Q1 | — | 26/199 |
| 2011 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 18/68 |
| 2011 | SURGERY | SCIE | Q1 | — | 23/199 |
| 2010 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 22/68 |
| 2010 | SURGERY | SCIE | Q1 | — | 30/188 |
| 2009 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 21/61 |
| 2009 | SURGERY | SCIE | Q1 | — | 21/167 |
| 2008 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 21/56 |
| 2008 | SURGERY | SCIE | Q1 | — | 21/148 |
| 2007 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 28/54 |
| 2007 | SURGERY | SCIE | Q1 | — | 33/139 |
| 2006 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 26/52 |
| 2006 | SURGERY | SCIE | Q1 | — | 28/137 |
| 2005 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 28/51 |
| 2005 | SURGERY | SCIE | Q1 | — | 28/139 |
| 2004 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 28/51 |
| 2004 | SURGERY | SCIE | Q2 | — | 39/139 |
| 2003 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 24/52 |
| 2003 | SURGERY | SCIE | Q2 | — | 37/141 |
| 2002 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 23/52 |
| 2002 | SURGERY | SCIE | Q2 | — | 40/141 |
| 2001 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 27/50 |
| 2001 | SURGERY | SCIE | Q2 | — | 40/139 |
| 2000 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | — | 25/45 |
| 2000 | SURGERY | SCIE | Q2 | — | 37/136 |
| 1999 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 22/44 |
| 1999 | SURGERY | SCIE | Q2 | — | 41/131 |
| 1998 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 17/39 |
| 1998 | SURGERY | SCIE | Q1 | — | 29/128 |
| 1997 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | — | 16/38 |
| 1997 | SURGERY | SCIE | Q1 | — | 24/114 |